Cancer patients often face a daunting reality: symptoms like pain, insomnia, and anxiety can escalate into emergency room visits, causing financial strain and emotional distress. But what if technology could step in and make a difference? A groundbreaking study from the Mayo Clinic reveals a powerful solution.
A small team of researchers has discovered a big impact by harnessing automation to keep cancer patients out of the ER. Led by Dr. Andrea Cheville, the study aimed to revolutionize cancer care through digital check-ins and remote support. The goal? To automate symptom check-ins and care, easing the burden on oncology teams while improving patients' lives.
And the results were remarkable. Patients like Becky Johnson, diagnosed with double breast cancer at 40, experienced better sleep and reduced anxiety. Johnson's participation in the Enhanced EHR-Facilitated Cancer Symptom Control Trial (E2C2) involved digital surveys about her health, which flagged insomnia as a concern. A nurse's phone call and an online sleep class based on cognitive behavioral therapy made a difference.
Here's where it gets innovative: the researchers developed automations in the Plummer Chart software, which manages patients' electronic health records (EHRs). This system automatically sorted patients' responses to surveys, providing tailored support. Mild symptoms were logged, moderate ones triggered self-care tips, and severe cases prompted remote care managers to reach out.
The software became a virtual guardian angel, streamlining information for care teams and making support more accessible for patients. The trial's success is evident: patients reported reduced anxiety and depression, and acute care encounters decreased by 40% to 60%.
This efficient approach required just a small care team, including 2-3 full-time care managers and partial support from a physician, to manage over 50,000 participants. The E2C2 trial demonstrates the potential of digital tools in cancer care, allowing a small team to support a large patient population effectively.
Dr. Cheville emphasizes the scalability of this method, envisioning its expansion beyond clinic walls. But here's where it gets controversial: while the study's success is undeniable, ensuring access to these tools for all healthcare teams remains a challenge. How can we make this innovative approach widely available, especially in underserved communities? The debate is open, and your insights are welcome.
